Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 2,615 shares at $25.58 ($67K) on 2024-03-12, disclosed to the SEC on 2024-03-12.
Scheduled sale ($67k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.70 | 1,585 | $41K | 60.7% |
| 2 | $25.58 | 1,030 | $26K | 39.3% |
| Total | $25.65 avg | 2,615 | $67K | 100% |
| Filing → |
| DYN | SELL | 2024-05-17 | $122K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |
| DYN | SELL | 2024-02-28 | $10K | — | Filing → |